← Back to Clinical Trials
Recruiting NCT06200116

NCT06200116 Evaluation of a Novel Auto Segmentation Algorithm for Normal Structure Delineation in Radiation Treatment Planning

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06200116
Status Recruiting
Phase —
Sponsor Mayo Clinic
Condition Malignant Solid Neoplasm
Study Type OBSERVATIONAL
Enrollment 200 participants
Start Date 2024-12-02
Primary Completion 2026-11-30

Trial Parameters

Condition Malignant Solid Neoplasm
Sponsor Mayo Clinic
Study Type OBSERVATIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2024-12-02
Completion 2026-11-30
Interventions
Non-Interventional Study

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This study measures the utility of a novel artificial intelligence (AI) algorithm for performing auto-segmentation of computed tomography (CT) scans for radiation therapy planning.

Eligibility Criteria

Inclusion Criteria: * Employment at Mayo Clinic Arizona, Florida, or Rochester (which includes Regional Practice sites located at Mayo Clinic Health System locations) as train clinical staff that participate in normal tissue segmentation Exclusion Criteria: * Inability to complete study surveys

Related Trials

VIEW ON CLINICALTRIALS.GOV ↗ MORE MALIGNANT SOLID NEOPLASM TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology